ERBB-2 overexpression as a risk factor for malignant phaeochromocytomas and paraganglinomas.
Wang W, Zhong X, Ye L, Qi Y, Su T, Wei Q, Xie J, Jiang L, Jiang Y, Zhou W, Cui B, Ning G.
Wang W, et al. Among authors: jiang l, jiang y.
Clin Endocrinol (Oxf). 2016 Jun;84(6):822-9. doi: 10.1111/cen.13019. Epub 2016 Feb 25.
Clin Endocrinol (Oxf). 2016.
PMID: 26749044